These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28814542)

  • 41. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
    Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
    Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
    Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
    Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fragile X syndrome in females - a familial case report and review of the literature.
    Stembalska A; Łaczmańska I; Gil J; Pesz KA
    Dev Period Med; 2016; 20(2):99-104. PubMed ID: 27442693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatricians' attitudes toward expanding newborn screening.
    Acharya K; Ackerman PD; Ross LF
    Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Progress in molecular diagnosis of fragile X syndrome].
    Guo XY; Liao J; Lan FH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):296-9. PubMed ID: 22678793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovering fragile X syndrome: family experiences and perceptions.
    Bailey DB; Skinner D; Sparkman KL
    Pediatrics; 2003 Feb; 111(2):407-16. PubMed ID: 12563071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and evaluation of a decision aid for inviting parents to participate in a fragile X newborn screening pilot study.
    Bailey DB; Lewis MA; Harris SL; Grant T; Bann C; Bishop E; Roche M; Guarda S; Barnum L; Powell C; Therrell BL
    J Genet Couns; 2013 Feb; 22(1):108-17. PubMed ID: 22736213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Pilot Study of Fragile X Syndrome Screening in Pregnant Women and Women Planning Pregnancy: Implementation, Acceptance, Awareness, and Geographic Factors.
    Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
    J Genet Couns; 2017 Jun; 26(3):501-510. PubMed ID: 27714485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A majority of parents accept newborn screening for fragile X.
    Levenson D
    Am J Med Genet A; 2011 Sep; 155A(9):viii-ix. PubMed ID: 21853527
    [No Abstract]   [Full Text] [Related]  

  • 52. FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome.
    Sherman SL; Kidd SA; Riley C; Berry-Kravis E; Andrews HF; Miller RM; Lincoln S; Swanson M; Kaufmann WE; Brown WT
    Pediatrics; 2017 Jun; 139(Suppl 3):S183-S193. PubMed ID: 28814539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility of an app-based mindfulness intervention among women with an FMR1 premutation experiencing maternal stress.
    Hunter JE; Jenkins CL; Grim V; Leung S; Charen KH; Hamilton DR; Allen EG; Sherman SL
    Res Dev Disabil; 2019 Jun; 89():76-82. PubMed ID: 30959430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylation analysis of fragile X-related epigenetic elements may provide a suitable newborn screening test for fragile X syndrome.
    Godler DE; Slater HR; Amor D; Loesch DZ
    Genet Med; 2010 Sep; 12(9):595. PubMed ID: 20838083
    [No Abstract]   [Full Text] [Related]  

  • 55. The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary.
    Riley C; Mailick M; Berry-Kravis E; Bolen J
    Pediatrics; 2017 Jun; 139(Suppl 3):S147-S152. PubMed ID: 28814536
    [No Abstract]   [Full Text] [Related]  

  • 56. "It's about having the choice": stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome.
    Archibald AD; Hickerton CL; Jaques AM; Wake S; Cohen J; Metcalfe SA
    Am J Med Genet A; 2013 Jan; 161A(1):48-58. PubMed ID: 23239566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fragile X syndrome detection in newborns-pilot study.
    Saul RA; Friez M; Eaves K; Stapleton GA; Collins JS; Schwartz CE; Stevenson RE
    Genet Med; 2008 Oct; 10(10):714-9. PubMed ID: 18813135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testing for fragile X gene mutations throughout the life span.
    Hagerman RJ; Hagerman PJ
    JAMA; 2008 Nov; 300(20):2419-21. PubMed ID: 19033593
    [No Abstract]   [Full Text] [Related]  

  • 59. Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.
    Ames AG; Jaques A; Ukoumunne OC; Archibald AD; Duncan RE; Emery J; Metcalfe SA
    Health Expect; 2015 Feb; 18(1):69-80. PubMed ID: 23067225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early Identification of Fragile X Syndrome through Expanded Newborn Screening.
    Okoniewski KC; Wheeler AC; Lee S; Boyea B; Raspa M; Taylor JL; Bailey DB
    Brain Sci; 2019 Jan; 9(1):. PubMed ID: 30609779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.